Brear and Constanti both have a Bachelor degree as their highest level of education. I certainly do not think you necessarily need a higher level of eduction than that to successfully run a company, but that does seem odd to me. And give the recent performance and complete inability of them to project sales and the recent pathetic guidance and misguided growth numbers, perhaps they should both go back to school for an MBA or something?
What actually is informative about it? More pumping BS that never ever comes to fruition? More pumping about how awesome SDN/NFV is and how PKT is going to the moon? You just want some article you can read and feel comfort from, don't you? Regardless of reality?
More pumping BS, yet this stock has as little interest in it as it's had in many years. Dumb articles pumping how awesome things are don't do anything to help the situation.
On IHUB they are still talking $20, $30...I've even seen $100+ suggested.
Joe Z said NCE was much ado about nothing. In other words, it isn't important. This is from Amarins' CEO! So people not to quit acting like this decision matters at all. Because it doesn't. No one cares about NCE when this company has much bigger issues to worry about.
Also, it's not a good idea to rely on a Judge to make you money.
We can hope, can't we?
Doesn't appear likely to happen, however. As each day passes with zero follow-up on the supposed "up for sale" sign, hope dwindles. We might be in this for the long haul with Brear leading the ship. It's frightening, but in 2 years from now, with great results and ZERO hiccups, we might see $15 again.
Low volume appears to be the new normal as the lack of interest in this stock continues. So even though volume might be low relative the last few years, it isn't too low relative recent trading. Low volume is the new normal.
Enough to make your blood boil to it's breaking point.
That is, unless are you are Sherry and Tartia, who just blindly accept his theft.
Raj has an amazing set-up going here. He can take millions out a year. And NO ONE can do ANYTHING about it. The performance of the stock/company is irrelevant to these millions. What a gig!!!
Your being serious? You can't blame management for their drug being a commercial failure? WOW. It's their job to make sure their superior product is a commercial success. Co-promoting with a little company that sells one other product is the way to do it? Think about what you are saying.
Company should have been sold eons ago and the product put into a proper sales force.
Vascepa has the same approval as Lovaza.
China is years away.
You obviously missed the message. The message is Vascepa should be doing 6x what Lovaza is doing. Yet the opposite is true. When I say Vascepa SHOULD be doing much higher than it currently is, that 's a compliment dude. The product isn't the issue with this company. It's the management.
Between Lovaza and generic Lovaza, they are doing over 6x as many scripts as Vascepa. This is an epic disaster of a drug launch. Well over two years on the market and they are still only selling a fraction of what Lovaza is doing. Time keeps on ticking while Vascepa still doesn't sell. Pathetic sales effort here. I would think it would be an EASY job to convince Lovaza prescribers to switch to Vascepa.
PKT had a dark cloud cover on Friday, which is a bearish reversal pattern. Google it to learn more. The trend may be back down now. Hopefully Brear has some actual news for us this week to help reverse the bearish trend for this week.
Down 36 cents on 30k shares since that point.
And it's back to PKT reality. 1.2x revenue was just getting too rich, hence the pullback. Gotta keep this valuation in check!